Status:

NOT_YET_RECRUITING

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Lead Sponsor:

Yan Bi

Conditions:

Diabetic Nephropathy Type 2

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The main purpose of this study is to explore the improvement of renal function before and after the intervention of dorzagliatin in patients with type 2 diabetes.

Detailed Description

As soon,metformin、SGLT-2i、GLP-1RA have been confirmed to have protective effect on the kidneys in the statement of consensus at home and abroad. Dorzagliatin exerts a potent hypoglycemic effect by act...

Eligibility Criteria

Inclusion

  • Age:18-75 years old, male and female.
  • Patients with type 2 diabetes mellitus, type 2 diabetes mellitus diagnosis criteria: according to the "Chinese Type 2 Diabetes Mellitus Prevention and Treatment Guide (2020 Edition).
  • UACR 30-299mg/g.
  • eGFR ≥60mL/min/1.73m².
  • HbA1c 7.0-10.5%.

Exclusion

  • Pregnant and lactating women and women of childbearing age who do not want to take reliable contraceptive measures.
  • Known allergic history to dorzagliatin/gliclazide/metformin.
  • Diabetic acute and chronic complications, including diabetic ketoacidosis, a hyperglycemic hyperosmolar state or hypoglycemic coma, etc.
  • Serious impairment of heart, liver, kidney and other organs.
  • With hypertension(≥140/90mmHg).
  • Fasting C-peptide \<300pmol/L.
  • Contraindications of MRI examination, such as implantation of metal prosthesis in vivo, claustrophobia, wearing insulin pumps, etc.

Key Trial Info

Start Date :

February 20 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT06222476

Start Date

February 20 2024

End Date

June 30 2026

Last Update

January 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University

Nanjing, Jiangsu, China, 210008

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study. | DecenTrialz